Physical Description
White to off-white powder
Identification
To pass tests A, B, C, D
Solubility (30% in water)
Clear, colourless solution
pH (30% in water)
4.0 - 6.8
1,4-Butane Sultone
≤ 0.5ppm
Sodium Chloride (NaCl)
≤ 0.2%
4-Hydroxybutane-1-sulfonic Acid
≤ 0.09%
Bis(4-sulfobutyl) Ether Disodium
≤ 0.05%
Total Aerobic Microbial Count
≤ 100CFU/g
Total Yeast and Mould Count
≤ 50CFU/g
Average Degree of Substitution
6.2 - 6.9
Pharmacopoeia Specification(s)
USP
Specification Version
1.1
Not classified as a hazardous substance or mixture
If you are publishing research using GP8988 please contact us to contribute to our list of citations.
Combined effects of quetiapine and opioids: A study of autopsy cases, drug users and sedation in rats
Freja Drost Andersen, Sâmia Joca, Victor Hvingelby, Shokouh Arjmand, Estefano Pinilla, Simon Comerma Steffensen, Ulf Simonsen, Charlotte Uggerhøj Andersen
Addiction Biology, e13214, 27(5) (2022)
Fatal opioid poisonings often involve methadone or morphine. This study aimed to elucidate if quetiapine, a widely used sedative antipsychotic medication, may increase the risk of fatal opioid poisoning by additive inhibitory effects on the central nervous system. We used data from 323 cases of fat…
read more
Disulfiram Inclusion Complexes - A Nebulization Approach to Fight COVID-19
Ana Maria Pereira, Ayse Kaya, Dan Alves, Niusha Ansari-Fard, Mohammad Najlah
British Journal of Pharmacy, , 7(2) (2022)
Disulfiram (DS) has an excellent anti-viral activity; however, its low water-solubility and first-pass metabolism are limiting its clinical applications. Cyclodextrins (CDs) have been used as solubility enhancers and carriers of DS proposed for inhalation to treat SARS-CoV-19. Two types of CDs (hyd…
read more
Australia
Austria
Belgium
Canada
Czech Republic
Denmark
France
Germany
Greece
Hungary
Ireland
Israel
Italy
Japan
Korea South
Netherlands
New Zealand
Norway
Poland
Portugal
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
United States
Vietnam
